EnteroMedics Company Profile (NASDAQ:ETRM)

About EnteroMedics

EnteroMedics logoEnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve. The Company's initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company's VBLOC therapy is designed to block the gastrointestinal effects of the vagus nerve by replicating a vagotomy using high-frequency, low-energy electrical impulses to intermittently interrupt naturally occurring neural impulses on the vagus nerve between the brain and the digestive system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ETRM
  • CUSIP: 29365M20
Key Metrics:
  • Previous Close: $6.64
  • 50 Day Moving Average: $8.63
  • 200 Day Moving Average: $2.29
  • 52-Week Range: $1.75 - $88.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.05
  • P/E Growth: 0.00
  • Market Cap: $10.34M
  • Outstanding Shares: 1,616,000
  • Beta: 2.21
Profitability:
  • Net Margins: -3,236.52%
  • Return on Equity: -1,361.34%
  • Return on Assets: -190.05%
Debt:
  • Debt-to-Equity Ratio: 1.07%
  • Current Ratio: 1.20%
  • Quick Ratio: 0.93%
Additional Links:
Companies Related to EnteroMedics:

Analyst Ratings

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $7.03 (9.84% upside)

Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetDetails
1/9/2017S&P Equity ResearchLower Price Target$17.19 -> $11.06View Rating Details
6/9/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $3.00View Rating Details
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00View Rating Details
7/20/2015Craig HallumLower Price TargetBuy$75.00 -> $30.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for EnteroMedics (NASDAQ:ETRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/17/2017        
8/4/2016Q216($0.75)($0.49)ViewN/AView Earnings Details
5/5/2016Q1($0.80)($0.94)ViewN/AView Earnings Details
2/17/2016Q315($0.90)($0.95)ViewListenView Earnings Details
8/6/2015Q215($0.10)($0.10)ViewN/AView Earnings Details
2/18/2015Q414($0.10)($0.09)ViewN/AView Earnings Details
11/12/2014Q3 14($0.10)($0.08)ViewN/AView Earnings Details
8/7/2014Q2($0.10)($0.11)ViewListenView Earnings Details
4/30/2014Q1 14($0.10)($0.10)ViewN/AView Earnings Details
2/12/2014Q413($0.10)($0.11)ViewN/AView Earnings Details
10/31/2013Q313($0.11)($0.11)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.13)($0.11)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.13)($0.14)$0.10 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.14)($0.17)$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EnteroMedics (NASDAQ:ETRM)
Current Year EPS Consensus Estimate: $-170.10 EPS
Next Year EPS Consensus Estimate: $-126.00 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.80)($0.05)($0.43)
Q2 20161($0.69)($0.69)($0.69)
Q3 20161($0.53)($0.53)($0.53)
Q4 20161($0.41)($0.41)($0.41)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for EnteroMedics (NASDAQ:ETRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for EnteroMedics (NASDAQ:ETRM)
Insider Ownership Percentage: 1.40%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2016Peter M DelangeSVPBuy20,000$0.55$11,000.00View SEC Filing  
8/13/2015Mark B KnudsonCEOBuy303,000$0.25$75,750.00View SEC Filing  
6/19/2014Cathy FriedmanDirectorBuy11,800$1.70$20,060.00View SEC Filing  
1/8/2014Luke EvninDirectorSell556,585$2.50$1,391,462.50View SEC Filing  
2/27/2013Anthony P JanszDirectorBuy150,000$0.95$142,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for EnteroMedics (NASDAQ:ETRM)
DateHeadline
streetinsider.com logoEnteroMedics (ETRM) Regains Compliance With Nasdaq Listing Requirement (NASDAQ:ETRM)
www.streetinsider.com - February 22 at 8:47 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics Inc. for Potential Breaches … (NASDAQ:ETRM)
finance.yahoo.com - February 22 at 8:47 AM
us.rd.yahoo.com logoEnteroMedics Regains Compliance With Nasdaq Listing Requirement (NASDAQ:ETRM)
us.rd.yahoo.com - February 22 at 8:47 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:ETRM)
us.rd.yahoo.com - February 22 at 8:47 AM
News IconWhat are analysts Suggestions on: Neurocrine Biosciences Inc. (NASDAQ:NBIX) (NASDAQ:ETRM)
oakridgeobserver.com - February 16 at 5:02 PM
News IconIs EnteroMedics Inc’s (ETRM) Balance Sheet A Threat To Its Future? (NASDAQ:ETRM)
simplywall.st - February 16 at 5:02 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:ETRM)
biz.yahoo.com - February 14 at 11:04 PM
News IconEnteroMedics Inc (NASDAQ:ETRM) Improves Its Pitch With Diabetes Data - Insider Financial (NASDAQ:ETRM)
www.insiderfinancial.com - February 12 at 3:12 AM
News IconHow Often Does EnteroMedics Inc. (ETRM) Beat Earnings Estimates? - Post Analyst (NASDAQ:ETRM)
postanalyst.com - February 11 at 3:39 AM
News IconEnteroMedics Inc ETRM Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ETRM)
www.bioportfolio.com - February 10 at 10:37 PM
streetinsider.com logoEnteroMedics (ETRM) Announces 3-Year Data from vBloc Diabetic Patient Study Published in Journal of Diabetes and Obesity (NASDAQ:ETRM)
www.streetinsider.com - February 10 at 3:42 AM
smarteranalyst.com logoStock Update (NASDAQ:ETRM): EnteroMedics Inc Announces Publication of Three-Year Data from vBloc Diabetic Patient Study (NASDAQ:ETRM)
www.smarteranalyst.com - February 9 at 5:40 PM
streetinsider.com logoEnteroMedics (ETRM) Announces 3-Year Data from vBloc Diabetic ... - StreetInsider.com (NASDAQ:ETRM)
www.streetinsider.com - February 9 at 5:40 PM
us.rd.yahoo.com logoEnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity (NASDAQ:ETRM)
us.rd.yahoo.com - February 9 at 5:40 PM
us.rd.yahoo.com logo7:02 am EnteroMedics announces the publication of three-year data from the Company's VBLOC DM2 Study of vBloc Neurometabolic Therapy in obese patients with Type 2 diabetes (NASDAQ:ETRM)
us.rd.yahoo.com - February 9 at 5:40 PM
News IconAnalyst Hints Surrounding EnteroMedics Inc. (ETRM) | Post Analyst - Post Analyst (NASDAQ:ETRM)
postanalyst.com - February 9 at 3:40 AM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Other Events (NASDAQ:ETRM)
biz.yahoo.com - February 8 at 5:35 PM
News IconEnteroMedics Inc. (NASDAQ:ETRM) now has Insider Ownership of 0% (NASDAQ:ETRM)
mundoaguaysaneamiento.net - February 7 at 6:14 PM
realistinvestor.com logoEnteroMedics Inc. (NASDAQ:ETRM) Is Expected To Post EPS Of $-27.972 - RealistInvestor.com (NASDAQ:ETRM)
www.realistinvestor.com - February 6 at 5:06 PM
News IconEnteroMedics Inc. (NASDAQ:ETRM) has industry P/E ratio of 61.67 - The Newburgh Press (NASDAQ:ETRM)
newburghpress.com - February 3 at 10:29 PM
News IconTechnical Reports on Medical Equipment Stocks -- EnteroMedics, Abbott Labs, Boston Scientific, and Medtronic (NASDAQ:ETRM)
www.kait8.com - February 1 at 10:42 PM
News IconIncrease in Volatility Draws Attention to Shares of EnteroMedics Inc. (NASDAQ:ETRM) - Wall Street Beacon (NASDAQ:ETRM)
wsbeacon.com - February 1 at 5:40 PM
News IconEnteroMedics Inc. (NASDAQ:ETRM) Stock ABR At 1 - Stock Observer (NASDAQ:ETRM)
www.thestockobserver.com - February 1 at 5:40 PM
realistinvestor.com logoEnteroMedics Inc. (NASDAQ:ETRM) EPS Projection At $-27.972 - RealistInvestor.com (NASDAQ:ETRM)
www.realistinvestor.com - January 31 at 2:28 AM
News IconHigh Volatility Moving the Needle For Shares of EnteroMedics Inc. (NASDAQ:ETRM) - Wall Street Beacon (NASDAQ:ETRM)
wsbeacon.com - January 31 at 2:28 AM
istreetwire.com logoTrader Alert: Wabash National Corporation (WNC), EnteroMedics Inc. (ETRM), InvenSense, Inc. (INVN) - iStreetWire (NASDAQ:ETRM)
istreetwire.com - January 27 at 6:45 PM
News IconHigh Volatility Creating Buzz Mid-Session For EnteroMedics Inc. (NASDAQ:ETRM) - Wall Street Beacon (NASDAQ:ETRM)
wsbeacon.com - January 27 at 6:45 PM
News IconAverage Price Target for EnteroMedics Inc. (NASDAQ:ETRM) is $140 - The Newburgh Press (NASDAQ:ETRM)
newburghpress.com - January 26 at 6:28 PM
News IconEnteroMedics Inc. (ETRM) Announces IPO Closing Figures - StockNewsUnion (NASDAQ:ETRM)
stocknewsunion.com - January 26 at 6:28 PM
News IconEnteroMedics Inc (NASDAQ:ETRM): Life After The Raise - Insider Financial (NASDAQ:ETRM)
www.insiderfinancial.com - January 26 at 6:28 PM
marketexclusive.com logoENTEROMEDICS INC. (NASDAQ:ETRM) Files An 8-K Other Events (NASDAQ:ETRM)
marketexclusive.com - January 25 at 6:26 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ETRM)
biz.yahoo.com - January 24 at 5:44 PM
News IconBroker Outlook For The Week Ahead EnteroMedics Inc. (ETRM) (NASDAQ:ETRM)
myhealthbowl.com - January 24 at 3:29 AM
News IconEnteroMedics closes $19m offering (NASDAQ:ETRM)
www.massdevice.com - January 23 at 10:28 PM
News IconAnalyst Ratings Buzz: EnteroMedics Inc (NASDAQ:ETRM)
perspectivabetica.com - January 23 at 10:28 PM
News IconStock in the Spotlight: EnteroMedics Inc (NASDAQ:ETRM) (NASDAQ:ETRM)
xboxonezone.com - January 23 at 10:28 PM
realistinvestor.com logoEPS Projection Of EnteroMedics Inc. (NASDAQ:ETRM) At $-27.972 - RealistInvestor.com (NASDAQ:ETRM)
www.realistinvestor.com - January 23 at 5:27 PM
News IconPriming The Pump: Stock Volatility Spotted in EnteroMedics Inc. (NASDAQ:ETRM) - Wall Street Beacon (NASDAQ:ETRM)
wsbeacon.com - January 23 at 5:26 PM
News IconEnteroMedics Inc: Why ETRM Stock Is Soaring - Profit Confidential (NASDAQ:ETRM)
www.profitconfidential.com - January 23 at 5:26 PM
finance.yahoo.com logoEnteroMedics Announces Closing of $19.0 Million Underwritten Public Offering and Full Exercise of Over-allotment Option (NASDAQ:ETRM)
finance.yahoo.com - January 23 at 5:26 PM
benzinga.com logoEnteroMedics Short Squeeze Is Back In Play (NASDAQ:ETRM)
www.benzinga.com - January 21 at 4:23 AM
rttnews.com logoEnteromedics Inc. (ETRM) Is Accelerating Higher In Early Trade (NASDAQ:ETRM)
www.rttnews.com - January 21 at 4:23 AM
istreetwire.com logoStocks Trend Analysis: EnteroMedics Inc. (ETRM) PulteGroup, Inc ... - iStreetWire (NASDAQ:ETRM)
istreetwire.com - January 20 at 6:21 PM
News IconEnteroMedics Inc. (NASDAQ:ETRM) showed monthly volitility of 34.91% - The Newburgh Press (NASDAQ:ETRM)
newburghpress.com - January 20 at 6:21 PM
seekingalpha.com logoEnteroMedics tries to regain momentum; shares up 51% (NASDAQ:ETRM)
seekingalpha.com - January 20 at 11:05 AM
News IconAmplified Volatility Spotted in Shares of EnteroMedics Inc. (NASDAQ:ETRM) - Wall Street Beacon (NASDAQ:ETRM)
wsbeacon.com - January 20 at 4:34 AM
News IconEnteroMedics Inc. (NASDAQ:ETRM) Quarterly Sales Review - The Newburgh Press (NASDAQ:ETRM)
newburghpress.com - January 19 at 6:31 PM
News IconHere's What EnteroMedics Inc (NASDAQ:ETRM) Needs To Do With Its Capital - Insider Financial (NASDAQ:ETRM)
www.insiderfinancial.com - January 19 at 6:31 PM
News IconEnteroMedics Inc: ETRM Stock Is Going Nuts … Again - Jutia Group (press release) (blog) (NASDAQ:ETRM)
jutiagroup.com - January 19 at 6:31 PM
seekingalpha.com logoEnteroMedics: Lose Weight Or Lose Your Money? (NASDAQ:ETRM)
seekingalpha.com - January 18 at 10:28 PM

Social

What is EnteroMedics' stock symbol?

EnteroMedics trades on the NASDAQ under the ticker symbol "ETRM."

When did EnteroMedics' stock split? How did EnteroMedics' stock split work?

Shares of EnteroMedics reverse split on Friday, January 8th 2016. The 1-15 reverse split was announced on Wednesday, December 23rd 2015. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 7th 2016. An investor that had 100 shares of EnteroMedics stock prior to the reverse split would have 7 shares after the split.

Where is EnteroMedics' stock going? Where will EnteroMedics' stock price be in 2017?

1 analysts have issued 12-month price targets for EnteroMedics' stock. Their predictions range from $3.00 to $11.06. On average, they expect EnteroMedics' stock price to reach $7.03 in the next twelve months.

When will EnteroMedics announce their earnings?

EnteroMedics is scheduled to release their next quarterly earnings announcement on Friday, February, 17th 2017.

Who owns EnteroMedics stock?

EnteroMedics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (10.07%) and CVI Investments, Inc (0.30%). Company insiders that own EnteroMedics stock include Mark B Knudson and Peter M Delange.

Who sold EnteroMedics stock? Who is selling EnteroMedics stock?

EnteroMedics' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy EnteroMedics stock?

Shares of EnteroMedics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of EnteroMedics stock cost?

One share of EnteroMedics stock can currently be purchased for approximately $6.40.

EnteroMedics (NASDAQ:ETRM) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for EnteroMedics (NASDAQ:ETRM)

Earnings History Chart

Earnings by Quarter for EnteroMedics (NASDAQ:ETRM)

Dividend History Chart

Dividend Payments by Quarter for EnteroMedics (NASDAQ:ETRM)

Last Updated on 2/23/2017 by MarketBeat.com Staff